Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?

Richert, Laura

Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints? [electronic resource] - AIDS (London, England) May 2013 - 1362-5 p. digital

Publication Type: Journal Article

1473-5571

10.1097/QAD.0b013e328360d52e doi


AIDS Vaccines--immunology
Clinical Trials as Topic
HIV Infections--immunology
HIV-1--immunology
Humans
Predictive Value of Tests
Reproducibility of Results
Viral Load